Exact Sciences
EXAS
$58.79
Share price
-7.04%
Change (1 day)
-11.21%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
EPS for Exact Sciences (EXAS)
EPS in 2023 (TTM): -$1.59
According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$1.59. In 2022 the company made an earnings per share (EPS) of -$3.54 a decrease over its 2021 EPS that were of -$3.46.
EPS history for Exact Sciences from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.59 | -55.21% |
| 2022 | -$3.54 | 2.31% |
| 2021 | -$3.46 | -37.09% |
| 2020 | -$5.50 | 674.65% |
| 2019 | -$0.71 | -50.69% |
| 2018 | -$1.44 | 44% |
| 2017 | -$1.00 | -39.39% |
| 2016 | -$1.65 | -2.94% |
| 2015 | -$1.70 | 37.1% |
| 2014 | -$1.24 | 79.71% |
| 2013 | -$0.69 | -21.59% |
| 2012 | -$0.88 | 62.96% |
| 2011 | -$0.54 | 92.86% |
| 2010 | -$0.28 | -3.45% |
| 2009 | -$0.29 | -19.44% |
| 2008 | -$0.36 | -18.18% |
| 2007 | -$0.44 | -10.2% |
| 2006 | -$0.49 | -10.91% |
| 2005 | -$0.55 | -24.66% |
| 2004 | -$0.73 | -51.33% |
| 2003 | -$1.50 | -7.41% |
| 2002 | -$1.62 | 11.72% |
| 2001 | -$1.45 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $3.18 | -300.57% | 🇫🇷 France |
 Veracyte VCYT | -$0.40 | -74.77% | 🇺🇸 USA |
 Antares Pharma ATRS | $0.34 | -121.44% | 🇺🇸 USA |
 Myriad Genetics MYGN | -$3.04 | 91.72% | 🇺🇸 USA |
 Biocept
BIOC | -$50.90 | 3,110.12% | 🇺🇸 USA |